Jennifer Hu

Dr. Jennifer Hu

Department of Public Health Sciences, Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, 1120 NW 14th St., CRB 1511, Miami, FL 33136, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2023 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AWAnqi Wang
Anqi Wang
JSJiayi Shen
Jiayi Shen
ARAlex A. Rodriguez
Alex A. Rodriguez
ESEdward J. Saunders
Edward J. Saunders
FCFei Chen
Fei Chen
CHChristopher A. Haiman
Christopher A. Haiman

13 August 2008 in Carcinogenesis
Verified
Journal Article
Closed access
TSTasha R. Smith
Tasha R. Smith
ELEdward A. Levine
Edward A. Levine
RFRita I. Freimanis
Rita I. Freimanis
SASteven A. Akman
Steven A. Akman
GAGlenn O. Allen
Glenn O. Allen
Jennifer HuJennifer Hu
Jennifer Hu
Genetic variations in DNA repair may impact repair functions, DNA damage and breast cancer risk. Using data/samples collected from the first 752 Caucasians and 141 African-Americans in an ongoing case-control study, we examined the association between breast cancer risk and 18 non-synonymous single-nucleotide polymorphisms (nsSNPs) in four DNA repair pathways-(i) base excision repair: ADPRT V762A, APE1 D148E, XRCC1 R194W/R280H/R399Q and POLD1 R119H; (ii) nucleotide excision repair: ERCC2 D312N/K751Q, ERCC4 R415Q, ERCC5 D1104H and XPC A499V/K939Q; (iii) mismatch repair: MLH1 I219V, MSH3 R940Q/T1036A and MSH6 G39E and (iv) double-strand break repair: NBS1 E185Q and XRCC3 T241M. In Caucasians, breast cancer risk was significantly associated with ADPRT 762VV [odds ratio (OR) = 1.45; 95% confidence interval (CI) = 1.03, 2.03], APE1 148DD (OR = 1.44; 95% CI = 1.03, 2.00), MLH1 219II/IV (OR = 1.87; 95% CI = 1.11, 3.16) and ERCC4 415QQ (OR = 8.64; 95% CI = 1.04, 72.02) genotypes. With a limited sample size, we did not observe any significant association in African-Americans. However, there were significant trends in breast cancer risk with increasing numbers of risk genotypes for ADPRT 762VV, APE1 148DD, ERCC4 415RQ/QQ and MLH1 219II/IV (P-trend < 0.001) in Caucasians and ADPRT 762VA, ERCC2 751KQ/QQ and NBS1 185EQ/QQ in African-Americans (P-trend = 0.006), respectively. Our results suggest that combined nsSNPs in multiple DNA repair pathways may contribute to breast cancer risk and larger studies are warranted to further evaluate polygenic models of DNA repair in breast cancer risk.

26 March 2021 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
ZDZhaohui Du
Zhaohui Du
GGGuimin Gao
Guimin Gao
BABabatunde Adedokun
Babatunde Adedokun
TAThomas Ahearn
Thomas Ahearn
KLKathryn L Lunetta
Kathryn L Lunetta
CHChristopher A Haiman
Christopher A Haiman
Polygenic risk scores (PRSs) have been demonstrated to identify women of European, Asian, and Latino ancestry at elevated risk of developing breast cancer (BC). We evaluated the performance of existing PRSs trained in European ancestry populations among women of African ancestry. We assembled genotype data for women of African ancestry, including 9241 case subjects and 10 193 control subjects. We evaluated associations of 179- and 313-variant PRSs with overall and subtype-specific BC risk. PRS discriminatory accuracy was assessed using area under the receiver operating characteristic curve. We also evaluated a recalibrated PRS, replacing the index variant with variants in each region that better captured risk in women of African ancestry and estimated lifetime absolute risk of BC in African Americans by PRS category. For overall BC, the odds ratio per SD of the 313-variant PRS (PRS313) was 1.27 (95% confidence interval [CI] = 1.23 to 1.31), with an area under the receiver operating characteristic curve of 0.571 (95% CI = 0.562 to 0.579). Compared with women with average risk (40th-60th PRS percentile), women in the top decile of PRS313 had a 1.54-fold increased risk (95% CI = 1.38-fold to 1.72-fold). By age 85 years, the absolute risk of overall BC was 19.6% for African American women in the top 1% of PRS313 and 6.7% for those in the lowest 1%. The recalibrated PRS did not improve BC risk prediction. The PRSs stratify BC risk in women of African ancestry, with attenuated performance compared with that reported in European, Asian, and Latina populations. Future work is needed to improve BC risk stratification for women of African ancestry.

13 May 2024 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
GJGuochong Jia
Guochong Jia
JPJie Ping
Jie Ping
XGXingyi Guo
Xingyi Guo
YYYaohua Yang
Yaohua Yang
RTRan Tao
Ran Tao
WZWei Zheng
Wei Zheng

14 January 2016 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
JWJean L. Wright
Jean L. Wright
CTCristiane Takita
Cristiane Takita
IRIsildinha M. Reis
Isildinha M. Reis
WZWei Zhao
Wei Zhao
ELEunkyung Lee
Eunkyung Lee
Jennifer HuJennifer Hu
Jennifer Hu
We evaluated predictors of radiation‐induced skin toxicity in a prospective study of a tri‐racial/ethnic breast cancer population. We evaluated patient demographics, tumor characteristics, and treatment variables in the first 392 patients in a prospective study assessing radiation‐induced skin toxicity. Logistic regression analyses were conducted to evaluate potential predictors of skin toxicity. The study consists of 59 non‐Hispanic whites (NHW; 15%), 241 Hispanic Whites (HW; 62%), 79 black or African Americans (AA; 20%), and 13 others (3%). Overall, 48% developed grade 0–1 skin toxicity, 49.8% grade 2, and 2.2% grade 3 by the National Cancer Institute's Common Toxicity Criteria for Adverse Events (CTCAE) scale. Twenty‐one percent developed moist desquamation. In multivariate analysis, higher body mass index (BMI; OR = 2.09; 95%CI = 1.15, 3.82), higher disease stage (OR = 1.82; 95%CI = 1.06, 3.11), ER‐positive/PR‐negative status (OR = 2.74; 95%CI = 1.26, 5.98), and conventionally fractionated regimens (OR = 3.25; 95%CI = 1.76, 6.01) were significantly associated with higher skin toxicity grade after adjustment for age, race, ethnicity, ER status, and breast volume. BMI specifically predicted for moist desquamation, but not degree of erythema. In this racially and ethnically diverse cohort of breast cancer patients receiving radiation to the intact breast, risk factors including BMI, disease stage, and conventionally fractionated radiation predicted for higher skin toxicity grade, whereas age, race, ethnicity, and breast volume did not. BMI specifically predicted for moist desquamation, suggesting that preventive measures to address this particular outcome should be investigated.

8 July 2008 in Journal of Human Genetics
Verified
Journal Article
Closed access
HLHui-Yi Lin
Hui-Yi Lin
WWWenquan Wang
Wenquan Wang
YLYung-Hsin Liu
Yung-Hsin Liu
SSSeng-Jaw Soong
Seng-Jaw Soong
TYTimothy P. York
Timothy P. York
Jennifer HuJennifer Hu
Jennifer Hu